A new trading day began on Tuesday, with Kura Oncology Inc (NASDAQ: KURA) stock price up 5.75% from the previous day of trading, before settling in for the closing price of $17.56. KURA’s price has ranged from $8.17 to $24.17 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged -18.07%. With a float of $65.88 million, this company’s outstanding shares have now reached $74.35 million.
In an organization with 142 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 48.82%, operating margin of -16694.65%, and the pretax margin is -15555.28%.
Kura Oncology Inc (KURA) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Kura Oncology Inc is 15.28%, while institutional ownership is 89.84%. The most recent insider transaction that took place on May 20 ’24, was worth 57,916. In this transaction Chief Legal Officer of this company sold 2,615 shares at a rate of $22.15, taking the stock ownership to the 68,979 shares. Before that another transaction happened on Jan 29 ’24, when Company’s SVP, Finance & Accounting sold 2,318 for $17.80, making the entire transaction worth $41,262. This insider now owns 48,093 shares in total.
Kura Oncology Inc (KURA) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around -18.07% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 19.93% during the next five years compared to -3.94% drop over the previous five years of trading.
Kura Oncology Inc (NASDAQ: KURA) Trading Performance Indicators
Here are Kura Oncology Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 11.47.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.36, a number that is poised to hit -0.66 in the next quarter and is forecasted to reach -2.72 in one year’s time.
Technical Analysis of Kura Oncology Inc (KURA)
Let’s dig in a bit further. During the last 5-days, its volume was 1.03 million. That was better than the volume of 0.9 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 57.27%. Additionally, its Average True Range was 0.87.
During the past 100 days, Kura Oncology Inc’s (KURA) raw stochastic average was set at 29.66%, which indicates a significant decrease from 64.12% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 41.63% in the past 14 days, which was higher than the 36.85% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $18.67, while its 200-day Moving Average is $20.16. However, in the short run, Kura Oncology Inc’s stock first resistance to watch stands at $19.53. Second resistance stands at $20.49. The third major resistance level sits at $21.26. If the price goes on to break the first support level at $17.80, it is likely to go to the next support level at $17.04. Assuming the price breaks the second support level, the third support level stands at $16.08.
Kura Oncology Inc (NASDAQ: KURA) Key Stats
With a market capitalization of 1.44 billion, the company has a total of 77,764K Shares Outstanding. Currently, annual sales are 0 K while annual income is -152,630 K. The company’s previous quarter sales were 0 K while its latest quarter income was -54,400 K.
